Teva Pharma (TEVA)
40.79
-0.06 (0.15%)
Upcoming Events
Latest Headlines
Teva Pharma (TEVA) PT Raised to $47 at Barclays
October 15, 2026 5:40 AM - StreetInsider
Teva to Host R&D Day on Wednesday, November 11 in New York City
October 12, 2026 5:45 PM - Globe NewsWire
Teva Pharma (TEVA) PT Raised to $50 at JPMorgan
October 12, 2026 5:30 AM - StreetInsider
Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer
October 9, 2026 12:03 PM - StreetInsider
Teva climbs premarket as FDA approves once-monthly schizophrenia treatment
October 9, 2026 8:23 AM - StreetInsider
Form 3 TEVA PHARMACEUTICAL INDU For: Sep 29 Filed by: Bergwerk Dov
October 8, 2026 4:01 PM - SEC Filing
TD Cowen Starts Teva Pharma (TEVA) at Buy
October 1, 2026 5:29 AM - StreetInsider
Samsung Bioepis and Teva expand biosimilar partnership to six candidates
October 1, 2026 4:30 AM - StreetInsider
Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
October 1, 2026 4:30 AM - BizWire
TAPI appoints Serge Rogasik as chief executive officer
September 30, 2026 4:32 PM - StreetInsider
TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness
September 30, 2026 4:32 PM - Globe NewsWire
FDA approves Teva's Degevma as biosimilar to Xgeva
September 28, 2026 4:04 PM - StreetInsider
Oppenheimer Starts Teva Pharma (TEVA) at Outperform
September 23, 2026 6:12 AM - StreetInsider
Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 14
September 22, 2026 5:10 PM - SEC Filing
Form 4 TEVA PHARMACEUTICAL INDU For: Sep 18 Filed by: Savage Brian
September 22, 2026 5:02 PM - SEC Filing
Form 4 TEVA PHARMACEUTICAL INDU For: Sep 19 Filed by: MIGNONE ROBERTO
September 22, 2026 4:22 PM - SEC Filing
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Savage Brian
September 21, 2026 6:40 AM - SEC Filing
Form 144 TEVA PHARMACEUTICAL INDU Filed by: BRIDGER MANAGEMENT, LLC
September 18, 2026 5:00 PM - SEC Filing
Teva shares Phase 3 data on once-monthly schizophrenia injection
September 18, 2026 4:30 PM - StreetInsider
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophren
September 18, 2026 4:30 PM - Globe NewsWire
Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 16
September 16, 2026 4:26 PM - SEC Filing
Teva Pharma (TEVA) call put ratio 1.7 calls to 1 put as share price down 0.79%
September 16, 2026 2:14 PM - StreetInsider
Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 14
September 14, 2026 4:07 PM - SEC Filing
Form 8-A12B/A TEVA PHARMACEUTICAL INDU
September 14, 2026 4:06 PM - SEC Filing
Form 25-NSE TEVA PHARMACEUTICAL INDU Filed by: NEW YORK STOCK EXCHANGE LLC
September 14, 2026 2:33 PM - SEC Filing
Form 424B5 TEVA PHARMACEUTICAL INDU
September 11, 2026 5:05 PM - SEC Filing
Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 09
September 11, 2026 4:06 PM - SEC Filing
Teva prices $4.9B senior notes offering to refinance debt
September 10, 2026 6:05 AM - StreetInsider
Form FWP TEVA PHARMACEUTICAL INDU Filed by: TEVA PHARMACEUTICAL INDUSTRIES LTD
September 10, 2026 6:05 AM - SEC Filing
Form FWP TEVA PHARMACEUTICAL INDU Filed by: TEVA PHARMACEUTICAL INDUSTRIES LTD
September 10, 2026 6:04 AM - SEC Filing
Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes
September 10, 2026 6:04 AM - Globe NewsWire
Leerink Starts Teva Pharma (TEVA) at Outperform
September 9, 2026 6:21 AM - StreetInsider
Form 424B5 TEVA PHARMACEUTICAL INDU
September 8, 2026 6:55 AM - SEC Filing
Teva Pharma (TEVA) PT Raised to $48 at UBS
September 7, 2026 5:26 AM - StreetInsider
Teva plans senior notes offering to refinance existing debt
September 7, 2026 3:53 AM - StreetInsider
Teva Announces Launch of Offering of Senior Notes
September 7, 2026 3:53 AM - Globe NewsWire
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
September 4, 2026 11:30 AM - Globe NewsWire
Teva Pharma (TEVA) PT Raised to $48 at UBS
September 4, 2026 5:46 AM - StreetInsider
Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 03
September 3, 2026 4:13 PM - SEC Filing
Form 8-K TEVA PHARMACEUTICAL INDU For: Aug 31
September 3, 2026 4:06 PM - SEC Filing
Teva's TEV '408 meets primary endpoint in celiac disease trial
September 2, 2026 7:08 AM - StreetInsider
Teva in talks with Trump administration on Medicaid drug pricing
August 31, 2026 4:08 PM - StreetInsider
Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.
August 31, 2026 4:06 PM - Globe NewsWire
Teva bids $57.5M for BioXcel agitation drug in bankruptcy sale
August 28, 2026 6:17 AM - StreetInsider
Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
August 28, 2026 6:17 AM - Globe NewsWire
Immuneering touts Phase 3 trial as FDA clears new pancreatic cancer drug
August 26, 2026 5:16 PM - StreetInsider
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
August 26, 2026 5:16 PM - Globe NewsWire
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 21 Filed by: Weiss Amir
August 25, 2026 4:05 PM - SEC Filing
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 21 Filed by: Satchi-Fainaro Ronit
August 25, 2026 4:03 PM - SEC Filing
Aurinia settles patent dispute with Teva over generic voclosporin
August 19, 2026 4:05 PM - StreetInsider
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 17 Filed by: Lippman Evan
August 19, 2026 4:01 PM - SEC Filing
FDA accepts Teva's drug application for Tourette syndrome therapy in children
August 19, 2026 8:56 AM - StreetInsider
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Lippman Evan
August 17, 2026 4:00 PM - SEC Filing
Teva Pharma (TEVA) PT Raised to $42 at Barclays
August 12, 2026 5:26 AM - StreetInsider
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 05 Filed by: Zaks Tal Zvi
August 10, 2026 6:08 AM - SEC Filing
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 03 Filed by: Jover Placid
August 5, 2026 4:05 PM - SEC Filing
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 03 Filed by: Hughes Eric A
August 5, 2026 4:03 PM - SEC Filing
Form 10-Q Immuneering Corp For: Jun 30
August 5, 2026 7:57 AM - SEC Filing
Form 8-K Immuneering Corp For: Aug 05
August 5, 2026 7:41 AM - SEC Filing
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Hughes Eric A
August 3, 2026 4:02 PM - SEC Filing
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Jover Placid
August 3, 2026 4:00 PM - SEC Filing
Form F-6 POS TEVA PHARMACEUTICAL INDU Filed by: Citibank,N.A./ADR
July 29, 2026 4:16 PM - SEC Filing
Form 10-Q TEVA PHARMACEUTICAL INDU For: Jun 30
July 29, 2026 4:02 PM - SEC Filing
Teva seeks clarity on Trump drug tariff plans, CEO says
July 29, 2026 10:21 AM - StreetInsider
UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
July 29, 2026 7:42 AM - BizWire
Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
July 29, 2026 7:24 AM - BizWire
Teva Pharma (TEVA) Misses Q2 EPS by 60c ; Offers Guidance
July 29, 2026 7:20 AM - StreetInsider
Form 8-K TEVA PHARMACEUTICAL INDU For: Jul 29
July 29, 2026 7:00 AM - SEC Filing
Form SCHEDULE 13G Immuneering Corp Filed by: BlackRock, Inc.
July 28, 2026 4:46 PM - SEC Filing
Teva Pharma (TEVA) PT Raised to $44 at Piper Sandler
July 28, 2026 7:14 AM - StreetInsider
Full Article List
